Neurochemical modulation of response inhibition and probabilistic learning in humans

被引:397
作者
Chamberlain, SR
Müller, U
Blackwell, AD
Clark, L
Robbins, TW
Sahakian, BJ
机构
[1] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Psychiat, Cambridge CB2 2QQ, England
[2] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England
[3] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
D O I
10.1126/science.1121218
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cognitive functions dependent on the prefrontal cortex, such as the ability to suppress behavior (response inhibition) and to learn from complex feedback (probabilistic learning), play critical roles in activities of daily life. To what extent do different neurochemical systems modulate these two cognitive functions? Here, using stop-signal and probabilistic learning tasks, we show a double dissociation for the involvement of noradrenaline and serotonin in human cognition. In healthy volunteers, inhibition of central noradrenaline reuptake improved response inhibition but had no effect on probabilistic learning, whereas inhibition of central serotonin reuptake impaired probabilistic learning with no effect on response inhibition.
引用
收藏
页码:861 / 863
页数:3
相关论文
共 40 条
[1]   Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions [J].
Arnsten, AFT ;
Li, BM .
BIOLOGICAL PSYCHIATRY, 2005, 57 (11) :1377-1384
[2]   The cognitive neuroscience of response inhibition: Relevance for genetic research in attention-deficit/hyperactivity disorder [J].
Aron, AR ;
Poldrack, RA .
BIOLOGICAL PSYCHIATRY, 2005, 57 (11) :1285-1292
[3]   Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans [J].
Aron, AR ;
Fletcher, PC ;
Bullmore, ET ;
Sahakian, BJ ;
Robbins, TW .
NATURE NEUROSCIENCE, 2003, 6 (02) :115-116
[4]   Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder [J].
Biederman, J ;
Spencer, T ;
Wilens, T .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (01) :77-97
[5]   Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in Attention Deficit/Hyperactivity Disorder [J].
Bymaster, FP ;
Katner, JS ;
Nelson, DL ;
Hemrick-Luecke, SK ;
Threlkeld, PG ;
Heiligenstein, JH ;
Morin, SM ;
Gehlert, DR ;
Perry, KW .
NEUROPSYCHOPHARMACOLOGY, 2002, 27 (05) :699-711
[6]   Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex [J].
Bymaster, FP ;
Zhang, W ;
Carter, PA ;
Shaw, J ;
Chernet, E ;
Phebus, L ;
Wong, DT ;
Perry, KW .
PSYCHOPHARMACOLOGY, 2002, 160 (04) :353-361
[7]  
Chamberlain Samuel R, 2004, Curr Psychiatry Rep, V6, P451
[8]   Strategy implementation in obsessive-compulsive disorder and trichotillomania [J].
Chamberlain, SR ;
Blackwell, AD ;
Fineberg, NA ;
Robbins, TW ;
Sahakian, BJ .
PSYCHOLOGICAL MEDICINE, 2006, 36 (01) :91-97
[9]   The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers [J].
Chamberlain, SR ;
Blackwell, AD ;
Fineberg, NA ;
Robbins, TW ;
Sahakian, J .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2005, 29 (03) :399-419
[10]  
CHAMBERLAIN SR, IN PRESS AM J PSYCHI